Lifestyle medicine and brain health: Insights from the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) and the promise of personalization

Abstract

The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) is a landmark 2‐year randomized clinical trial evaluating multidomain lifestyle interventions for dementia prevention in older adults at elevated risk. Its effectiveness and national reach represent an important step towards scaling prevention science in diverse, real‐world settings. However, the trial also underscores a persistent challenge in lifestyle medicine: the prioritization of feasibility over optimization. In this commentary, we review U.S. POINTER through a precision medicine lens and outline strategies to integrate standardized core elements with flexible, individualized components that can amplify both potency and applicability. We emphasize three priorities: (1) tailoring interventions to drive physiological adaptations; (2) leveraging the synergistic potential of related behavioral domains; and (3) targeting sleep and circadian health as central intervention components. While U.S. POINTER advances feasibility and community participation, a more tailored, mechanistically informed approach could increase effect sizes and extend benefits to populations historically excluded in prevention research. Personalized strategies should not be confined to pharmacology—they must also guide behavioral interventions. Designing lifestyle programs that stimulate measurable adaptations, leverage behavioral synergy, and align with circadian biology offers the potential to produce greater and more durable cognitive benefits.

Highlights

• The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) trial demonstrates that complex, multidomain interventions are feasible, acceptable, and capable of producing measurable cognitive benefits across large, heterogenous populations.

• While effective, U.S. POINTER produced modest effect sizes, suggesting that some components may not have been sufficiently potent or specific to elicit maximal benefits.

• To advance beyond feasibility, future multidomain lifestyle interventions should (1) tailor interventions to drive physiological adaptations; (2) leverage the synergistic potential of related behavioral domains; and (3) target sleep and circadian health as central intervention components.

1. INTRODUCTION

Modeled after the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), ¹ the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) ² tested a multidomain lifestyle intervention in older adults at increased risk for dementia. This multisite, randomized 2‐year clinical trial provides proof of concept for delivering and sustaining complex behavioral programs in large, heterogeneous, community‐based populations: demonstrating feasibility, adherence, and measurable cognitive improvements. Lifestyle medicine remains the leading edge of dementia prevention research, and the U.S. POINTER trial advances our understanding of how to implement these strategies at scale. Here, we examine the trial's strengths, identify methodological gaps, and propose opportunities to increase potency, personalization, and long‐term impact.

2. STRENGTHS AND KEY FINDINGS

The U.S. POINTER trial enrolled 2111 participants from five geographically distinct regions of the United States, encompassing a broad spectrum of ethnoracial backgrounds. Participants were aged 60 to 79 years, who reported physical inactivity, a suboptimal diet, and an elevated risk of cognitive decline. Participants were randomized to a structured lifestyle intervention (STR) or a self‐guided control (SG). The STR participants received coach‐supported, aerobic exercise training (30–35 min, 4 times per week), resistance exercise training (15–20 min, twice per week), and flexibility work (10–15 min, twice per week); Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND) diet counseling; computerized cognitive training (15–20 min, 3 times per week) with group discussions; and vascular risk monitoring. The SG participants attended six group sessions over 2 years, received general health materials, and made changes independently without coaching or adherence tracking.

Over 2 years, the STR group exhibited significantly greater gains in global cognition than the SG group (annual change = 0.243 SD vs. 0.213 SD; between‐group difference = 0.029 SD, p = 0.008). Benefits were observed across demographic and genetic subgroups, including apolipoprotein E epsilon 4 (APOE ε4) carriers. Participants with lower baseline cognition improved the most, suggesting that early intervention in those already experiencing decline may yield the largest returns. High retention and adherence rates (> 80%) within the heterogenous, at‐risk population further emphasize feasibility and real‐world context.

3. LIMITATIONS AND METHODOLOGICAL CONSIDERATIONS

While effective, the intervention produced modest effect sizes—comparable to those reported in previous multidomain lifestyle interventions, ³ , ⁴ suggesting that some components may not have been sufficiently potent or specific to elicit maximal benefits. Future trials should adopt integrated, mechanistically informed approaches that target measurable physiological adaptations, leverage domain synergy, and include key behaviors such as sleep and circadian alignment.

3.1. Tailoring interventions to enhance physiological adaptations

The U.S. POINTER trial successfully increased physical activity in previously sedentary older adults. However, while measures of physical fitness and function (e.g., heart rate, 400‐m Walk Test, Short Physical Performance Battery) were collected, none were reported. Without these outcomes, it is impossible to determine whether the exercise intervention—or its individual components—improved physical performance or mediated cognitive benefits. Furthermore, without objectively assessing changes in cardiorespiratory fitness through a maximal exercise test (e.g., V̇O_2max), the extent to which physiological adaptations occurred, and whether they influenced the observed effects, remains unknown. The resistance training prescription was also likely underdosed and under‐specified: low‐to‐moderate intensity sessions, twice weekly for 15 to 20 min, using resistant bands, exercise balls, and light free weights. The protocol lacked detail on exercise selection, set and repetition schemes, rest intervals, progression, and training to fatigue—all of which are fundamental principles for stimulating fast‐twitch (type II) muscle fibers and eliciting meaningful strength and metabolic adaptations. ⁵ Further compounding this limitation is the fact that neither muscle mass nor strength gains were reported, leaving neuromuscular contributions to cognitive performance unknown.

Considering that exercise was a cornerstone of this multidomain intervention, the absence of physical performance and body composition outcomes raises a critical question: was the exercise prescription potent enough to trigger the physiological changes required to influence brain health?

3.2. Leveraging the synergistic potential of lifestyle interventions

U.S. POINTER's multidomain design reflects the multifactorial nature of dementia risk, but these components were largely implemented as independent, albeit parallel, interventions. This approach may have missed opportunities to capitalize on well‐characterized interactions between domains.

For example, protein and carbohydrate intake timed before and after resistance training can significantly enhance muscle protein synthesis, strength gains, and recovery. ⁶ In contrast, performing aerobic exercise immediately before resistance training may blunt anabolic signaling, thereby limiting hypertrophy and strength development. ⁷ Conversely, engaging in aerobic exercise shortly before a cognitive task has been shown to acutely improve executive function, likely through altered cerebral blood flow and neuronal activity. ⁸ Furthermore, the timing of these behaviors (e.g., diet, exercise, and so forth) relative to each other can influence metabolic efficiency, hormonal rhythms, and neurocognitive function. ⁹

These interactions highlight the importance of sequencing and timing in multidomain interventions. Future trials should explicitly design protocols to align behaviors for maximum synergy. For example, pairing resistance training with timely protein intake, scheduling aerobic exercise before cognitive training sessions, as well as avoiding combinations that may counteract positive effects. This requires precise prescription, rigorous adherence tracking, and systematic evaluation of alternative sequencing strategies.

3.3. Integrating sleep and circadian health as core intervention domains

Despite strong evidence linking sleep and circadian alignment to brain health, ¹⁰ neither was included as an intervention in the U.S. POINTER study design. Insufficient sleep and circadian disruption contribute to amyloid‐β and tau protein accumulation, impaired glymphatic clearance, and exacerbate vascular and metabolic dysfunction. ¹¹ Sleep is also essential for memory consolidation and synaptic plasticity, both of which are central to cognitive health. ¹² In addition to sleep duration, quality, and regularity, thoughtful attention should be given to the synergistic effects of sleep and circadian health with other key lifestyle factors (diet, exercise, and cognitive engagement), as misalignment between biological rhythms and behavioral timing across the 24‐h period is linked to increased risk for metabolic syndrome, cardiovascular disease, and cognitive decline. ¹³ For example, sleep quality may influence the cognitive benefits of exercise, highlighting circadian health as a synergistic contributor to lifestyle intervention effectiveness. ¹⁴ Notably, POINTER‐zzz, an ancillary study to characterize sleep‐related outcomes was conducted in a subset of the U.S. POINTER participants. While these data have not been released, they could provide critical insights about sleep's role in future dementia trials.

Integrating sleep and circadian health into multidomain interventions could include:

• Objective monitoring using accelerometry and wearable devices;

• Personalized sleep hygiene and strategies for maintaining circadian health;

• Coordinating exercise and meal timing with circadian acrophases in physical performance and metabolic activity;

• Avoiding cognitively demanding tasks during circadian troughs.

These measures add minimal burden and high potential for substantially enhancing intervention potency and durability.

4. TOWARD PERSONALIZED THERAPIES

Precision medicine principles, including baseline characterization, targeted dosing, and adaptive modification, must be implemented in behavioral interventions. Individual differences in genetics, physiology, comorbidities, and environmental influences can shape intervention efficacy. ¹⁵ For example, while the U.S. POINTER study did not find cognitive differences based on the APOE ε4allele, APOE ε4 carriers may respond differently to exercise ¹⁶ or dietary fat ¹⁷ ; just as individuals with insulin resistance may require targeted carbohydrate timing. ¹⁸

Personalization within a standardized framework requires knowledge of one's baseline status, allowing for scalability while preserving individual tailoring, which is a more clinically meaningful alternative to a one‐size‐fits‐all prescription in dementia prevention.

5. NEXT STEPS AND RESEARCH OPPORTUNITIES

To advance beyond feasibility, future multidomain lifestyle interventions should:

1. Report physical fitness, strength, and body composition outcomes alongside cognitive measures.

2. Report the frequency, intensity, time, type, and time‐of‐day details for each domain (see Table 1 below).

3. Incorporate baseline physiological testing to inform individualized prescription.

4. Integrate domain synergy through deliberate sequencing and timing of intervention components.

5. Include sleep and circadian alignment as primary intervention domains.

6. Use adaptive designs—such as incorporating Sequential, Multiple Assignment, Randomized Trial (SMART) ¹⁹ design considerations, or applying the trial principles of the Multiphase Optimization Strategy (MOST) ²⁰ to adjust dosages according to participant responsiveness.

TABLE 1.

Essential reporting details for each intervention domain

Detail	Definition	Example
Frequency	How often a repeating activity occurs.	Resistance training occurred twice per week.
Intensity	Magnitude or strength of the activity.	Squats: Three sets of six repetitions at 85% of one repetition maximum.
Time	Length or duration of the activity.	Walking occurred for 30 min/session.
Type	Mode or form of the activity.	Walking, cycling, incline bench press, and squats.
Time‐of‐day	When the activity occurred.	Aerobic exercise session began at 11:25 am.

Such strategies can clarify who benefits most, why, and under what conditions.

6. CONCLUSION

The U.S. POINTER trial demonstrates that complex, multidomain interventions are feasible, acceptable, and capable of producing measurable cognitive benefits across large, heterogenous populations. However, its modest effect sizes highlight the need to pivot from proving that lifestyle modifications work to determining how to optimize them. By prescribing exercise to elicit measurable adaptations, aligning behavioral domains for maximal synergy, and integrating sleep and circadian health, future programs can more fully harness the potential of lifestyle medicine to yield clinically meaningful benefits for brain and cognitive health and reduce dementia risk.

CONFLICT OF INTEREST STATEMENT

All authors report no conflicts of interest. Ryan J. Dougherty is an Associate Editor of Alzheimer's & Dementia—Translational Research and Clinical Investigations, and has not been involved in the review process or decisions based on its outcomes. Author disclosures are available in the supporting information.

Supporting information

Supporting Information

Alfini A, Dougherty RJ. Lifestyle medicine and brain health: Insights from the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) and the promise of personalization. Alzheimer's Dement. 2025;11:e70180. 10.1002/trc2.70180